Table 4.
COPD1 | IPF2 | CF3 | |
---|---|---|---|
Area Under the Curve | 0.553 | 0.591 | 0.584 |
Variable | |||
Age 18 – 25 | 6.20 | 14.4 | −0.0959*** |
Age 25 – 35 | −0.0450 | −0.0268 | −0.0257 |
Age 35 – 45 | −0.0488* | 0.0421 | 0.0149 |
Age 45 – 55 | 0.0310* | 0.0208 | 0.00333 |
Age 55 – 65 | 0.0338*** | 0.00613 | 0.149 |
Age 65+ | 0.132** | −0.0121 | −0.418 |
Female vs. Male | --- | --- | −0.220* |
Body Mass Index | --- | 0.0168 | --- |
Creatinine | 0.161* | --- | --- |
Total Bilirubin | 0.0141 | 0.0409*** | --- |
Pulmonary Variables | --- | --- | --- |
Oxygen Requirement, L/min |
0.0337 | 0.0525** | --- |
Carbon Dioxide, mEq/L | --- | --- | --- |
FEV1 (L) | −0.00230 | −0.00595 | --- |
FVC (L) | --- | --- | --- |
6 minute walk test < 150 feet |
--- | --- | --- |
Mechanical ventilation | --- | 0.353 | --- |
Hemodynamic Variables | |||
Cardiac Output (L/min) | −0.0417 | −0.0452 | −0.0538 |
Wedge Pressure (mm Hg) | --- | --- | --- |
Systolic Pulmonary Artery Pressure | --- | --- | --- |
Recipient Viral Status | |||
CMV positive status | --- | --- | −0.142 |
EBV positive status | −0.253 | −0.136 | |
HCV positive status | --- | --- | --- |
Co-morbidities | |||
Diabetes | 0.183 | --- | 0.264* |
Hypertension | --- | --- | --- |
Cancer | −0.218 | --- | |
Transfusion History | 0.235 | --- | 0.337 |
Peptic Ulcer | --- | --- | 0.322 |
Cerebral Vascular | --- | --- | --- |
Corticosteroid user | 0.153* | --- | --- |
COPD: Chronic Obstructive Pulmonary Disease and alpha-1 antitrypsin deficiency
IPF: Idiopathic Pulmonary Fibrosis
CF: Cystic Fibrosis
p < .05,
p < .01,
p < .001